Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563.
On page 554, the sentence “Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treating fibrosis…” contains an error. The term “antifibrinogenic” should be replaced by “antifibrogenic”.
On page 558, (D), the intermediate block corresponding to SNAC is missing. The correct figure is shown below.
Figure 3 Representative picrosirius red staining images of hepatic histology of (A) control, (B) nonalcoholic steatohepatitis (NASH), and (C) S-nitroso-N-acetylcysteine (SNAC) treated animals. Magnification is × 200. (D) Collagen quantification of the control, SNAC, and NASH groups.
